Lestaurtinib is a potent inhibitor of anaplastic thyroid cancer cell line models.
Pinto N, Prokopec SD, Vizeacoumar F, Searle K, Lowerison M, Ruicci KM, Yoo J, Fung K, MacNeil D, Lacefield JC, Leong HS, Mymryk JS, Barrett JW, Datti A, Boutros PC, Nichols AC.
Pinto N, et al. Among authors: lowerison m.
PLoS One. 2018 Nov 12;13(11):e0207152. doi: 10.1371/journal.pone.0207152. eCollection 2018.
PLoS One. 2018.
PMID: 30419054
Free PMC article.